Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, C. J.
Right arrow Articles by Thrasher, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, C. J.
Right arrow Articles by Thrasher, A. J.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Brief Reports
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 August 2000, Vol. 96, No. 4, pp. 1591-1593

BRIEF REPORT

Polarized expression of bone morphogenetic protein-4 in the human aorta-gonad-mesonephros region

Caroline J. Marshall, Christine Kinnon, and Adrian J. Thrasher

From the Molecular Immunology Unit, Institute of Child Health, London, UK.


    Abstract
Top
Abstract
Introduction
Study design
Results and discussion
References

In the mammal, definitive hematopoietic stem cells (HSCs) are first derived from mesodermal cells within a region of the embryonic para-aortic splanchnopleura known as the aorta-gonad-mesonephros (AGM). Within this region, HSCs are thought to arise from hemangioblast precursors located in the ventral wall of the dorsal aorta. However, the factors that regulate HSC development in vivo are still largely unknown. Bone morphogenetic protein (BMP)-4, a member of the transforming growth factor beta (TGF-beta ) superfamily of growth factors, is a potent ventralizing factor and has been implicated in the commitment of embryonic mesodermal cells to a hematopoietic fate in a number of systems. In the human AGM, we find that BMP-4 is expressed at high levels, and with striking polarity, in a region of densely packed cells underlying intra-aortic hematopoietic clusters. In contrast, TGF-beta 1 is expressed predominantly by hematopoietic cells within the clusters. These findings implicate both BMP-4 and TGF-beta 1 in the initiation and regulation of hematopoiesis in the human AGM. Furthermore, the distribution of BMP-4 expression is highly suggestive of a direct role in the specification of human hematopoietic cells from embryonic mesoderm in vivo. (Blood. 2000;96:1591-1593)

© 2000 by The American Society of Hematology.

    Introduction
Top
Abstract
Introduction
Study design
Results and discussion
References

The major source of definitive murine HSCs has been mapped to the embryonic AGM, at a time when clusters of hematopoietic cells are found adhering to the ventral wall of the dorsal aorta.1,2 The appearance of clusters is restricted to between 9.5 to 11.5 days post coitum in the mouse and 30 to 37 days gestation in the human.3,4 These cell clusters express a number of molecules in common with endothelial cells lining the wall of the dorsal aorta, including the membrane glycoprotein CD34, the transcription factors SCL and GATA-2, and the growth factors receptor c-Kit and FLK-1.5,6 The shared expression patterns and the close physical association between the HSC cluster and the endothelium has led to the suggestion that both lineages arise from a common hemangioblast precursor located within or underlying the wall of the dorsal aorta. In addition, the marked asymmetry of this process suggests that cluster formation is not a stochastic event, but one that is determined by microenvironmental signals localized to the ventral aortic wall.

Thus far, the factors that regulate hemangioblast differentiation in vivo remain unknown although analysis of hematopoietic development in lower vertebrates suggests that members of the TGF-beta superfamily of secreted polypeptide growth factors, including the bone morphogenetic proteins (BMP) play a critical role. During embryogenesis, BMPs are thought to specify a variety of cell fates dependent on concentration gradients, and expression of antagonistic factors such as activin and noggin.7 One family member, BMP-4, is known to induce ventral mesoderm, the tissue that will eventually give rise to the hematopoietic system. Evidence from studies using Xenopus laevis suggests that BMP-4 is also involved in the commitment of mesodermal cells to the blood lineage.8 In Xenopus, HSCs arise in the embryonic ventral mesoderm, which contains the dorsal lateral plate, a region analogous to the mammalian AGM. Ectoderm-derived animal cap cells, which do not normally give rise to blood cells, can be induced to do so in vivo after treatment with ectopic BMP-4. After mesoderm has formed, expression of a dominant negative BMP-4 receptor inhibits normal hematopoietic development, and mutant embryos lacking BMP-4 expression also fail to develop hematopoietic tissue. These data support a role for BMP-4 not only in mesoderm formation but also in the conversion of mesoderm to blood, possibly by regulating the temporal and spatial expression of necessary transcription factors within the hemangioblast population.

The involvement of BMP-4 in the initiation of mammalian hematopoiesis has been less easy to study. For example, mice lacking BMP-4 seldom develop beyond the egg cylinder stage, preceding the appearance of blood cells because of a critical requirement during gastrulation. However, in rare cases where homozygous mutants have developed to later stages, there is a noticeable paucity of blood cells circulating in the vasculature.10 On the other hand, the addition of BMP-4 to murine embryonic stem (ES) cells results in the acquisition of mesodermal markers and development of myeloid hematopoietic precursors. Interestingly, the dose of BMP-4 required for mesoderm formation from ES cells is considerably lower than that required for maximal hematopoietic output, suggesting that BMP-4 is sufficient to initiate hematopoiesis from existing mesodermal tissues, but in a concentration dependent manner.11

Unlike BMPs, TGF-beta 1 itself is not thought to be directly associated with dorsoventral patterning, but is an important regulator of cell proliferation and differentiation in a variety of tissues during embryogenesis. Mice lacking TGF-beta 1 mainly die in utero between 9.5 to 11.5 days post coitum because of defects in yolk sac hematopoiesis and vasculogenesis.12 In addition, TGF-beta 1 has been shown to inhibit the initial proliferation and differentiation of murine long-term repopulating HSCs and primitive human long-term culture-initiating cells.13,14 Early human hematopoietic progenitors themselves secrete TGF-beta 1, and it has been suggested that this autocrine production may be important in the negative regulation of cell cycling.15


    Study design
Top
Abstract
Introduction
Study design
Results and discussion
References

Human tissue collection and processing

Human embryos and yolk sacs were obtained from the MRC-funded Human Embryo Bank maintained at the Institute of Child Health. The embryos were staged and processed as previously described.6

Immunohistochemistry

Paraffin-embedded tissue sections through human embryos at 28, 34, and 38 days gestation and human yolk sacs were pretreated and antibody-binding visualized as described previously.6 Transverse sections were incubated with mouse monoclonal antibodies raised against human BMP-4 (clone 3H2: Novocastra Laboratories, UK) and TGFbeta 1 (clone TGFB17: Novocastra Laboratories, UK). For TGFbeta 1, a high-temperature antigen-unmasking technique was used.6 Sections were incubated with primary antibody for 60 minutes at room temperature. Results shown are representative.


    Results and discussion
Top
Abstract
Introduction
Study design
Results and discussion
References

Immunohistochemical analysis of the human embryonic AGM reveals clusters of hematopoietic cells associated with the ventral wall of the dorsal aorta. These cells express the membrane glycoprotein CD34 and the hematopoietic-specific marker CD45.4,6 We have also previously reported the presence of a morphologically distinct region resembling a stromal layer in the mesenchyme directly beneath the ventral wall of the dorsal aorta in the AGM that is associated with intra-aortic clusters. This consists of between 5 and 7 layers of densely packed cells in the 34-day human embryo (Figure 1A and B) or 3 to 4 layers in the mouse at 10.5 days post coitum, and expresses high levels of the extracellular matrix protein tenascin-C (data not shown6). In view of their emerging importance in the development of hematopoiesis, we investigated whether expression of members of the TGF-beta family is localized to this region. In the 34-day human embryo, BMP-4 was expressed in a gradient across the dorsoventral axis with many highly positive cells distributed throughout the ventral mesoderm, including transected descending neuronal tracts (Figure 1A). Within the AGM region, compared with the surrounding tissues and adjacent cardinal vessels, expression of BMP-4 was polarized to the ventral wall of the dorsal aorta, specifically in the region of the "stromal" layer and underlying the intra-aortic clusters (Figure 1B). At 28 days gestation, no distinct dorsoventral gradient of expression was apparent, neuronal tracts were absent and BMP-4 expression within the ventral mesoderm was generally low, with few strongly positive cells (Figure 1C). However, at this earlier developmental stage, emerging clusters of hematopoietic cells were also found adhering to the ventral wall of the dorsal aorta and BMP-4 expression was strikingly restricted to the "stromal" layer, which consisted of only 2 or 3 layers of cells at this age, underlying these clusters (Figure 1D).


View larger version (86K):
[in this window]
[in a new window]
 
Figure 1. Expression of transforming growth factors BMP-4 and TGFbeta 1 in the human embryonic AGM region. Immunohistochemical analysis on transverse sections of human embryos and yolk sac. (A) Within the AGM region at 34 days, a gradient of BMP-4 protein exists across the dorsoventral axis at the level of the AGM region. BMP-4 is expressed in the ventral mesoderm (below thin arrows), which includes the dorsal aorta (da), cardinal veins (cv), and mesonephros (m), whereas the dorsal mesoderm (above thin arrows), between the dorsal aorta and neural tube (nt), is predominantly negative. (B) Higher magnification of (A) in the region of the dorsal aorta. BMP-4 expression is polarized to the ventral stromal region (s) underlying the intra-aortic hematopoietic cluster (hc). (C) In contrast, in a younger 28-day-old embryo, BMP-4 is expressed at low level in both ventral and dorsal mesoderm, with few highly positive cells. (D) However, as shown by a higher magnification of (C), BMP-4 expression is at this stage restricted to the thin "stromal" layer (s) underlying the ventral wall of the aorta from which a cluster of cells (hc) can be seen emerging. (E) At more caudal levels (34 days), no intra-aortic clusters are visible and BMP-4 expression is markedly lower than in the AGM, consistent with an anterior-posterior progression of development during embryogenesis. (F) At 38 days gestation, BMP-4 expression within the AGM region is relatively uniform around the entire aorta and is not polarized to the ventral wall. (G) Cells expressing BMP-4 (arrows) are specifically associated with blood islands (bi) in the embryonic yolk sac (31 days). (H) TGFbeta 1 is expressed by cells within the intra-aortic cluster (hc). Uniformly low level expression is detected around the aorta. (Original magnification: A, C, ×15; B, D, E, G, H ×78, F ×36).

Outside the AGM, at more caudal and rostral locations, the level of BMP-4 expression was comparatively low and no hematopoietic clusters were observed (Figure 1E and data not shown). Similarly, in older (38-day) embryos, after intra-aortic clusters have disappeared, BMP-4 expression around the dorsal aorta was no longer polarized (Figure 1F). Interestingly, the analysis of human embryonic yolk sac also revealed strong BMP-4 expression in cells specifically associated with blood islands (Figure 1G).

We also investigated the expression pattern of TGF-beta 1. In contrast to BMP-4, the expression of TGF-beta 1 was uniformly low around the dorsal aorta, but detectable at higher levels in the cytoplasm of hematopoietic cells within the intra-aortic clusters (Figure 1H). No positive staining was observed in controls using normal serum or secondary antibody only.

In summary, we find that BMP-4 is expressed at high levels in a cell-dense region underlying the ventral wall of the dorsal aorta at the time of human AGM hematopoiesis. Taken together with evidence from other developmental systems, this may be a critical requirement for the initiation of a hematopoietic differentiation program from mesodermal precursors. The factors that regulate expression of BMP-4, and downstream signaling events that determine this process are at present unclear, but may involve tightly regulated expression (spatial and temporal) of transcription factors such as Tal-1/SCL, Lmo2, GATA-2, and AML1/Cbfa2, a member of the family of core-binding transcription factors.16-20 For example, in a parallel system, the induction of core-binding factor AML3 by BMP family members has been shown to be tightly linked to the process of osteoblastic differentiation.21,22 AML1 is now known to be required for definitive hematopoiesis23,24 and is transiently expressed in cells in the ventral wall of the dorsal aorta in the murine AGM coincident with the appearance of hematopoietic clusters.20 In the embryonic AGM, BMP-4 may therefore directly influence the conversion of hemangioblasts to committed HSCs through induction of AML1. The contrasting expression patterns of BMP-4 and TGF-beta 1 in the embryonic AGM are consistent with a role for BMP-4 in the initiation of HSC development from mesodermal precursors, and for TGF-beta 1, possibly together with BMP-4, in the regulation of hematopoietic cell fate.


    Acknowledgment

We would like to thank Rachel Moore for preparation of embryonic tissue used in this study.


    Footnotes

Submitted February 7, 2000; accepted April 12, 2000.

Supported by Grants 044783/Z/95 and 057965/Z/99 from the Wellcome Trust, UK. A.J.T. is a Wellcome Trust Senior Clinical Fellow.

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.

Reprints: Caroline J. Marshall, Molecular Immunology Unit, Institute of Child Health, 30 Guilford St, London, WC1N 1EH, United Kingdom; email: c.marshall{at}ich.ucl.ac.uk.


    References
Top
Abstract
Introduction
Study design
Results and discussion
References

1. Muller AM, Medvinsky A, Strouboulis J, Grosveld F, Dzierzak E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity. 1994;1:291-301[Medline] [Order article via Infotrieve].

2. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell. 1996;86:897-906[Medline] [Order article via Infotrieve].

3. Wood HB, May G, Healy L, Enver T, Morriss-Kay GM. CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood. 1997;90:2300-2311[Abstract/Free Full Text].

4. Tavian M, Coulombel L, Luton D, San Clemente H, Dieterlen-Lievre F, Peault B. Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood. 1996;87:67-72[Abstract/Free Full Text].

5. Labastie MC, Cortes F, Romeo PH, Dulac C, Peault B. Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood. 1998;92:3624-3635[Abstract/Free Full Text].

6. Marshall CJ, Moore RL, Thorogood P, Brickell PM, Kinnon C, Thrasher AJ. Detailed characterization of the human aorta-gonad-mesonephros region reveals morphological polarity resembling a hematopoietic stromal layer. Dev Dyn. 1999;215:139-147[Medline] [Order article via Infotrieve].

7. Hogan BLM. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996;10:1580-1594[Free Full Text].

8. Huber TL, Zhou Y, Mead PE, Zon LI. Cooperative effects of growth factors involved in the induction of hematopoietic mesoderm. Blood. 1998;92:4128-4137[Abstract/Free Full Text].

9. Zhang C, Evans T. BMP-like signals are required after the midblastula transition for blood cell development. Dev Genet. 1996;18:267-278[Medline] [Order article via Infotrieve].

10. Winnier G, Blessing M, Labosky PA, Hogan BLM. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995;9:2105-2116[Abstract/Free Full Text].

11. Johansson BM, Wiles MV. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol. 1995;15:141-151[Abstract].

12. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. Defective hematopoiesis and vasculogenesis in transforming growth factor beta 1 knock out mice. Development. 1995;121:1845-1854[Abstract].

13. Sitnicka E, Ruscetti FW, Priestley GV, Wolf NS, Bartelmez SH. Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood. 1996;88:82-88[Abstract/Free Full Text].

14. Garbe A, Spyridonidis A, Mobest D, Schmoor C, Mertelsmann R, Henschler R. Transforming growth factor beta-1 delays formation of granulocyte-macrophage colony forming cells, but spares more primitive progenitors during ex vivo expansion of CD34+ haematopoietic progenitor cells. Br J Haematol. 1997;99:951-958[Medline] [Order article via Infotrieve].

15. Hatzfeld J, Li ML, Brown EL, et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides. J Exp Med. 1991;174:925-929[Abstract/Free Full Text].

16. Mead PE, Kelley CM, Hahn PS, Piedad O, Zon LI. SCL specifies hematopoietic mesoderm in Xenopus embryos. Development. 1998;125:2611-2620[Abstract].

17. Manaia A, Lemarchandel V, Klaine M, et al. Lmo2 and GATA-3 associated expression in intraembryonic hemogenic sites. Development. 2000;127:643-653[Abstract].

18. Maeno M, Mead PE, Kelley C, et al. The role of BMP-4 and GATA-2 in the induction and differentaition of hematopoietic mesoderm in Xenopus leavis. Blood. 1996;88:1965-1972[Abstract/Free Full Text].

19. Minegishi N, Ohta J, Yamagiwa H, et al. The mouse GATA-2 gene is expressed in the para-aortic splanchnopleura and aorta-gonads and mesonephros region. Blood. 1999;93:4196-4207[Abstract/Free Full Text].

20. North T, Gu TL, Stacy T, et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 1999;126:2563-2575[Abstract].

21. Tsuji K, Ito Y, Noda M. Expression of PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type 1 collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells. Bone. 1998;22:87-92[Medline] [Order article via Infotrieve].

22. Lee MH, Javed A, Kim HJ, et al. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta 1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem. 1999;73:114-125[Medline] [Order article via Infotrieve].

23. Okuda T, van Duersen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosome translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 1996;84:321-320[Medline] [Order article via Infotrieve].

24. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A. 1996;93:3444-3449[Abstract/Free Full Text].

© 2000 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
D. C. Goldman, A. S. Bailey, D. L. Pfaffle, A. Al Masri, J. L. Christian, and W. H. Fleming
BMP4 regulates the hematopoietic stem cell niche
Blood, November 12, 2009; 114(20): 4393 - 4401.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Peeters, K. Ottersbach, K. Bollerot, C. Orelio, M. de Bruijn, M. Wijgerde, and E. Dzierzak
Ventral embryonic tissues and Hedgehog proteins induce early AGM hematopoietic stem cell development
Development, August 1, 2009; 136(15): 2613 - 2621.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Durand, C. Robin, K. Bollerot, M. H. Baron, K. Ottersbach, and E. Dzierzak
Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells
PNAS, December 26, 2007; 104(52): 20838 - 20843.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. E. Pimanda, I. J. Donaldson, M. F. T. R. de Bruijn, S. Kinston, K. Knezevic, L. Huckle, S. Piltz, J.-R. Landry, A. R. Green, D. Tannahill, et al.
The SCL transcriptional network and BMP signaling pathway interact to regulate RUNX1 activity
PNAS, January 16, 2007; 104(3): 840 - 845.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. E. Lenox, J. M. Perry, and R. F. Paulson
BMP4 and Madh5 regulate the erythroid response to acute anemia
Blood, April 1, 2005; 105(7): 2741 - 2748.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Y. Bertrand, S. Giroux, R. Golub, M. Klaine, A. Jalil, L. Boucontet, I. Godin, and A. Cumano
Characterization of purified intraembryonic hematopoietic stem cells as a tool to define their site of origin
PNAS, January 4, 2005; 102(1): 134 - 139.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. M. Bond, M. Mesuraca, E. Carbone, P. Bonelli, V. Agosti, N. Amodio, G. De Rosa, M. Di Nicola, A. M. Gianni, M. A. S. Moore, et al.
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells
Blood, March 15, 2004; 103(6): 2062 - 2070.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Chadwick, L. Wang, L. Li, P. Menendez, B. Murdoch, A. Rouleau, and M. Bhatia
Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells
Blood, August 1, 2003; 102(3): 906 - 915.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Nosaka, S. Morita, H. Kitamura, H. Nakajima, F. Shibata, Y. Morikawa, Y. Kataoka, Y. Ebihara, T. Kawashima, T. Itoh, et al.
Mammalian Twisted Gastrulation Is Essential for Skeleto-Lymphogenesis
Mol. Cell. Biol., April 15, 2003; 23(8): 2969 - 2980.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. E. Jay, L. Gallacher, and M. Bhatia
Emergence of muscle and neural hematopoiesis in humans
Blood, October 16, 2002; 100(9): 3193 - 3202.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Graf, S. Nethisinghe, D. B. Palmer, A. G. Fisher, and M. Merkenschlager
The Developmentally Regulated Expression of Twisted Gastrulation Reveals a Role for Bone Morphogenetic Proteins in the Control of T Cell Development
J. Exp. Med., July 15, 2002; 196(2): 163 - 171.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Guo, A. Pui-yee Chan, H. Liang, E. D. Wieder, J. J. Molldrem, L. D. Etkin, and L. Nagarajan
A human Mix-like homeobox gene MIXL shows functional similarity to Xenopus Mix.1
Blood, June 17, 2002; 100(1): 89 - 95.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
I. E. Kochanowska, K. Wlodarski, A. Wojtowicz, A. Kinsner, and K. Ostrowski
BMP-4 and BMP-6 Involvement in the Osteogenic Properties of the HeLa Cell Line
Experimental Biology and Medicine, January 1, 2002; 227(1): 57 - 62.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, C. J.
Right arrow Articles by Thrasher, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, C. J.
Right arrow Articles by Thrasher, A. J.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Brief Reports
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020